IN-DATE
384008: BD Introsyte-N Autoguard Shielded Introducer 26G x 0.70mm
Sign in to add this product to your favorites!
| Price: | $149.00 per box of 10 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 10 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 12 hours 59 minutes and choose overnight shipping at checkout. |
Related Items
QUICK VIEW
| 384031 - Size: 22G $15.00 EACH BD Introsyte-N Precision Introducer (Conventional) 22G Expired Units in stock: 18 | Order Qty |
QUICK VIEW
| 384021 - Size: 26G $5.00 EACH BD Introsyte-N Precision Introducer (Conventional) 26G Expired Units in stock: 39 | Order Qty |
QUICK VIEW
| 384008 - Size: 26G $15.00 EACH BD Introsyte-N Autoguard Shielded Introducer 26G x 0.70mm Expired Units in stock: 4 | Order Qty |
AccessGUDID Info
- FDA Product Code: DYB
- FDA Product Code Name: Introducer, catheter
- GMDN Term Code: 58865
- GMDN Term Name: Vascular catheter introduction set, nonimplantable
- GMDN Term Description: A collection of nonimplantable, invasive devices intended to provide percutaneous vascular access to enable introduction of a catheter (not included) into the vascular system. It includes a non-steerable introducer sheath with an inner obturator/dilator, and typically an additional access device(s) [e.g., guidewire, introducer needle, syringe, additional dilators] which may include a haemostatic valve to control blood loss, usually to enable arterial access. This is a single-use device.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
